Premier Alternatives

Gate Bioscience

Brisbane, CA · Founded 2021 · Privately Held (backing)

Developer of small molecule drugs designed to selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease. Gate Bioscience is based in Brisbane, CA and was founded in 2021. Its last reported valuation was $161 million in Nov 2025. It has raised $135 million.

Last reported valuation
$161.0M
Oct 2026
Priced at
—
Total raised
$134.5M
Last round
—

Gate Bioscience key facts

as of Oct 2026
  • Developer of small molecule drugs designed to selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease.
  • Gate Bioscience is valued at approximately $161.0M as of Oct 2026 (last reported valuation).
  • It has raised $134.5M; the latest was Early Stage VC ($65.0M) in Nov 2025.
  • Notable investors include Andreessen Horowitz, GV, ARCH Venture Partners, Forbion, Versant Ventures — 6 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$161.0M

Gate Bioscience's last reported valuation, Nov 2025. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Gate Bioscience with a free account
  • ·Watch Gate Bioscience: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Gate Bioscience funding rounds

No rounds on record

No funding rounds for Gate Bioscience are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Gate Bioscience valuation

Gate Bioscience's last reported valuation was $161 million in Nov 2025. No priced round, secondary trade or fund mark has surfaced since.

Gate Bioscience investors

6 investors are on record for Gate Bioscience, including Andreessen Horowitz, GV, ARCH Venture Partners and Forbion. By type, the record holds 5 venture capital firms.

About Gate Bioscience

Developer of small molecule drugs designed to selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease. The company combines a privileged library of molecular gates, a suite of bespoke secretion-focused assays and technologies, and expertise in the biology of the secretory pathway to enable precise, rapid, and repeatable drug development, enabling doctors to address a wide range of diseases with a single therapeutic mechanism.

Sector
Healthcare
HQ
Brisbane, CA, United States
Founded
2021
Employees
42
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.